Quantum BioPharma Concludes Initial Tranche of Offering

Quantum BioPharma Ltd. (NASDAQ:QNTM), based in Toronto, has successfully completed the initial tranche of its offering, issuing 500 Debenture Units for CAD 500,000. The funds will support further business development and general working capital needs. The securities from this tranche are subject to a holding period of four months and a day.

The company's debentures are no longer secured by general security from Quantum BioPharma. All financial figures in the announcement are presented in Canadian dollars. Importantly, the securities are not registered under the U.S. Securities Act of 1933 and cannot be sold within the U.S. without meeting specific conditions. This announcement does not represent an offer or solicitation to sell these securities in any unauthorized region.